Related Experiment Videos
Screening HLA to Prevent Severe Drug Reactions-A Devil's Advocate Perspective
1Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA Dermatology
|March 28, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Blistering Drug Eruptions: Diagnostic Challenges and Management in Clinical Practice: Unmasking the Cause: A Grand Rounds Review of Blistering Drug Eruption.
The journal of allergy and clinical immunology. In practice·2026
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets.
The Journal of clinical investigation·2024
Updates in SJS/TEN: collaboration, innovation, and community.
Frontiers in medicine·2023
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
The Journal of clinical investigation·2020
SJS/TEN 2019: From science to translation.
Journal of dermatological science·2020
Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa.
JAMA dermatology·2026
Pyoderma Gangrenosum Phenotype Classification.
JAMA dermatology·2026
Early Respiratory Infection Burden and Atopic Dermatitis in Childhood.
JAMA dermatology·2026
Tested but unprotected? Uncovering missed opportunities in hepatitis B prevention among health professionals in Sierra Leone.
The Pan African medical journal·2026
Post-polypectomy surveillance documentation and guideline concordance: A retrospective clinical audit of physician documentation at a tertiary Saudi hospital.
Journal of Taibah University Medical Sciences·2026
A retrospective analysis of COVID-19 vaccination uptake among patients admitted to psychiatric hospitals in southwest Bavaria.
Journal of psychiatric research·2026
Future is NOW (Non-violent Options Win): mixed methods evaluation of a primary violence prevention program.
Trauma surgery & acute care open·2026